|
Market Closed -
OTC Markets
15:50:39 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0785 USD | +3.29% |
|
+19.57% | -16.45% |
| 11-12 | MariMed Inc., Q3 2026 Earnings Call, Nov 12, 2026 | |
| 11-11 | MariMed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 30.23M 27.39M 25.34M 22.86M 43.08M 2.85B 44.6M 304M 121M 1.52B 113M 111M 4.83B | P/E 2026 * |
-1.88x | P/E 2027 * | -2.5x |
|---|---|---|---|---|---|
| Enterprise Value | -43.28M -39.22M -36.28M -32.73M -61.68M -4.08B -63.86M -436M -173M -2.18B -162M -159M -6.92B | EV / Sales 2026 * |
-0.26x | EV / Sales 2027 * | -0.26x |
| Free-Float |
85.37% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: MariMed Inc.
| 1 day | +3.29% | ||
| 1 week | +19.57% | ||
| Current month | +52.72% | ||
| 1 month | +25.20% | ||
| 3 months | +22.56% | ||
| 6 months | -5.42% | ||
| Current year | -16.45% |
| 1 week | 0.06 |  | 0.08 |
| 1 month | 0.05 | | 0.08 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.05 | | 0.16 |
| 3 years | 0.05 | | 0.39 |
| 5 years | 0.05 | | 0.98 |
| 10 years | 0.05 | | 5.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Levine
CEO | Chief Executive Officer | 61 | 2022-12-13 |
Mario Pinho
DFI | Director of Finance/CFO | 58 | 2024-08-08 |
Jay O’Malley
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Gildea
CHM | Chairman | 74 | 2023-02-27 |
Jon Levine
BRD | Director/Board Member | 61 | 2015-12-31 |
David Allen
BRD | Director/Board Member | 71 | 2019-06-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/15/26 | Option | Chief Financial Officer | 38,282 | 0.0095% | ||
| 10/15/26 | Tax | Executive/Senior Manager | -9,631 | 0.0024% | ||
| 10/15/26 | Option | Chief Executive Officer | -30,625 | 0.0076% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.29% | +19.57% | -12.89% | -76.07% | 30.23M | |
| -1.12% | -5.97% | -37.16% | +7.85% | 16.72B | |
| +0.12% | +1.67% | -8.74% | +15.21% | 7.09B | |
| +2.73% | +1.34% | -6.42% | +9.29% | 6.7B | |
| -2.39% | -9.22% | -51.28% | -39.51% | 6.03B | |
| -22.13% | -2.72% | -36.21% | -45.51% | 4.44B | |
| +2.54% | -4.50% | +2.58% | -19.28% | 4.51B | |
| +0.89% | -1.30% | +5.36% | -19.49% | 3.46B | |
| +0.74% | +2.42% | -11.81% | -27.40% | 3.3B | |
| +0.28% | +24.20% | +56.96% | - | 3.13B | |
| Average | -1.51% | +1.12% | -9.96% | -21.66% | 6B | |
| Weighted average by Cap. | -1.70% | -0.98% | -18.54% | -7.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 167M 152M 140M 126M 238M 15.77B 247M 1.68B 668M 8.42B 627M 614M 26.73B | 169M 153M 141M 128M 240M 15.91B 249M 1.7B 674M 8.5B 633M 620M 26.97B |
| Net income | -14.95M -13.55M -12.53M -11.31M -21.31M -1.41B -22.06M -151M -59.7M -753M -56.12M -54.93M -2.39B | -10.8M -9.79M -9.06M -8.17M -15.4M -1.02B -15.94M -109M -43.14M -544M -40.55M -39.69M -1.73B |
| Net Debt | -73.51M -66.61M -61.61M -55.59M -105M -6.93B -108M -740M -293M -3.7B -276M -270M -11.75B | -73.71M -66.8M -61.78M -55.74M -105M -6.95B -109M -742M -294M -3.71B -277M -271M -11.79B |
Employees
866
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | US$0.0703 | -6.29% | 368,709 |
| 26-11-12 | US$0.0750 | +0.67% | 404,658 |
| 26-11-11 | US$0.0745 | +2.76% | 1,419,244 |
| 26-11-10 | US$0.0725 | -3.82% | 1,568,230 |
| 26-11-09 | US$0.0754 | +12.51% | 6,060,899 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0750
Average target price
-
- Stock Market
- Stocks
- MRMD Stock
Select your edition
All financial news and data tailored to specific country editions
